Geistlich Pharma
Elena Dolgodilina, PhD, is a Regulatory Compliance Manager at Geistlich Pharma AG, with experience in medical device registrations in the EU and ROW, compliance with ISO standards, and collaboration with various departments and notified bodies. Prior to this role, Elena served as a Scientific & Medical Writer at BeeMed, focusing on orthopedic and sports medicine literature, and as a Scientific/3R Coordinator at ETH Zurich, where responsibilities included promoting the 3Rs principle in animal experimentation and organizing educational events. Elena's academic background includes a PhD in Integrative Molecular Medicine/Physiology from the University of Zurich, complemented by a Master's in Biology and Biochemistry, and a Bachelor's in Biotechnology and Biochemistry from Belarusian State University.
This person is not in any offices
Geistlich Pharma
1 followers
Geistlich Pharma AG develops, produces and distributes medical devices and drugs (anti-infectives, vitamins) for regenerative medicine at the Wolhusen and Root sites in central Switzerland. The Swiss company forms part of the Geistlich group which has been in family hands since 1851. Geistlich Pharma and its three business units Geistlich Biomaterials, Geistlich Surgery and Geistlich Medical have ten subsidiaries and global distribution. Some 500 employees work for the company around the world. The company is a world leader in regenerative dentistry through its business unit Geistlich Biomaterials. The ownership structure enables the company to plan long-term and to consistently develop innovative products. Geistlich Pharma AG continuously invests in developing its research and technology and relies on its qualified and specialized employees. Currently Geistlich Pharma is - the global market leader in regenerative dentistry - the leader in biological bone and cartilage regeneration - supplies drugs and medical devices in selected application areas